A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.

Panagiotis Heras Antonios Hatzopoulos Vasilios Heras Nikolaos Kritikos Stefanos Karagiannis Konstantinos Kritikos

Am J Ther

General Hospital of Nafplio, Department of Internal Medicine, Nafplio, Greece.

Published: September 2011

We compared the effects of ibandronate and pamindronate in patients with bone metastases from breast or lung cancer and we found that ibandronate is superior to pamindronate in alleviating pain, improving mobility and quality of life, and reducing bone resorption indices in patients with bone metastases from breast or lung cancer.

Download full-text PDF	Source
http://dx.doi.org/10.1097/MJT.0b013e3181e70c38	DOI Listing

Publication Analysis

Top Keywords

patients bone

bone metastases

metastases breast

breast lung

lung cancer

ibandronate pamindronate

pamindronate patients

bone

comparative study

study intravenous

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!